<2>Breakthrough in Sleep Apnea Treatment: Scientists Discover Promising Pill
European Clinical Trial Yields Encouraging Results
<3>Sulthiame Shows Potential in Reducing Breathing Interruptions
Sulthiame, a medication previously used to treat epilepsy, has been found to significantly reduce breathing interruptions in people with moderate to severe sleep apnea. A recent European clinical trial demonstrated that patients taking higher doses of sulthiame experienced up to 47% fewer pauses in breathing and improved oxygen levels during sleep.
How Sulthiame Works
<3>Stabilizing Breathing Signals in the Brain
The drug helps stabilize breathing signals in the brain, reducing airway collapse and the resulting breathing interruptions. This mechanism of action makes sulthiame a promising alternative to traditional treatments for sleep apnea, such as continuous positive airway pressure (CPAP) machines.
Paving the Way for a Pill-Based Alternative
<3>Scientists Hail the Findings as a Major Breakthrough
Scientists involved in the study believe that the findings could pave the way for a pill-based alternative to CPAP machines. This could